| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |